ROQAF
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
Capitalization
2.91M
SNTI
Price
$2.16
Change
+$0.05 (+2.37%)
Updated
Jun 27 closing price
Capitalization
56.34M
Interact to see
Advertisement

ROQAF vs SNTI

Header iconROQAF vs SNTI Comparison
Open Charts ROQAF vs SNTIBanner chart's image
Roquefort Therapeutics
Price$0.05
Change-$0.00 (-0.00%)
Volume$600
Capitalization2.91M
Senti Biosciences
Price$2.16
Change+$0.05 (+2.37%)
Volume$92.21K
Capitalization56.34M
ROQAF vs SNTI Comparison Chart in %
Loading...
SNTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ROQAF vs. SNTI commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ROQAF is a Buy and SNTI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (ROQAF: $0.05 vs. SNTI: $2.16)
Brand notoriety: ROQAF and SNTI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ROQAF: 100% vs. SNTI: 35%
Market capitalization -- ROQAF: $2.91M vs. SNTI: $56.34M
ROQAF [@Biotechnology] is valued at $2.91M. SNTI’s [@Biotechnology] market capitalization is $56.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ROQAF’s FA Score shows that 1 FA rating(s) are green whileSNTI’s FA Score has 1 green FA rating(s).

  • ROQAF’s FA Score: 1 green, 4 red.
  • SNTI’s FA Score: 1 green, 4 red.
According to our system of comparison, SNTI is a better buy in the long-term than ROQAF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNTI’s TA Score shows that 3 TA indicator(s) are bullish.

  • SNTI’s TA Score: 3 bullish, 5 bearish.

Price Growth

ROQAF (@Biotechnology) experienced а 0.00% price change this week, while SNTI (@Biotechnology) price change was +1.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

SNTI is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNTI($56.3M) has a higher market cap than ROQAF($2.91M). ROQAF YTD gains are higher at: 0.000 vs. SNTI (-38.462).
ROQAFSNTIROQAF / SNTI
Capitalization2.91M56.3M5%
EBITDAN/A-54.96M-
Gain YTD0.000-38.462-
P/E RatioN/A5.84-
RevenueN/A0-
Total CashN/A33.8M-
Total DebtN/A32.4M-
TECHNICAL ANALYSIS
Technical Analysis
SNTI
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
67%
Momentum
ODDS (%)
Bearish Trend 1 day ago
58%
MACD
ODDS (%)
Bearish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
61%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
72%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Declines
ODDS (%)
Bearish Trend 6 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
63%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Interact to see
Advertisement
SNTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RYAN67.580.35
+0.52%
Ryan Specialty Holdings
LRCX97.200.36
+0.37%
Lam Research Corp
OCSL13.56-0.01
-0.04%
Oaktree Specialty Lending Corp
NVNI0.30N/A
-0.71%
Nvni Group Limited
EAF1.06-0.05
-4.50%
GrafTech International Ltd

ROQAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROQAF has been loosely correlated with GNTA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ROQAF jumps, then GNTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROQAF
1D Price
Change %
ROQAF100%
N/A
GNTA - ROQAF
36%
Loosely correlated
+1.81%
CRBP - ROQAF
22%
Poorly correlated
-6.61%
SVRA - ROQAF
21%
Poorly correlated
N/A
SKYE - ROQAF
21%
Poorly correlated
-2.33%
SNTI - ROQAF
6%
Poorly correlated
+2.37%
More